Clarifying the Optimal Application of SLT Therapy Trial
University of Pittsburgh
Summary
The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Age 18 or older and in good health 2. Each eye with one of the following qualifying diagnoses (diagnoses may differ between eyes): 1. High-risk ocular hypertension (OHT): IOP \> 21 mmHg without glaucomatous optic neuropathy (excavation, diffuse or focal thinning or notching of the neuroretinal rim, visible nerve fiber layer defects, or asymmetry of the vertical cup-to-disc ratio of \>0.2 between eyes) 2. Mild primary open-angle glaucoma: glaucomatous optic neuropathy, visual field mean deviation better than -6.0 dB with no points in the central 5° \<15 dB (see fi…
Interventions
- ProcedureLow Energy SLT
SLT performed at low energy
- ProcedureStandard Energy SLT
SLT performed at standard energy
Locations (29)
- Harvard Eye AssociatesLaguna Hills, California
- Doheny Eye Center UCLAPasadena, California
- University of California, DavisSacramento, California
- University of California, San FranciscoSan Francisco, California
- Mile High Eye InstituteSheridan, Colorado
- Clear Vue Laser Eye CenterLakeworth, Florida